Propanc Biopharma, Inc. (PPCB) NASDAQ
0.11
+0.0131(+13.44%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.11
+0.0131(+13.44%)
Currency In USD
| Market Cap | 16.47M |
| Enterprise Value | 18.18M |
| P/E Ratio | -0.02 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 55.95 |
| Price/Book Ratio | 0.14 |
| Enterprise/Revenue | 93.51 |
| Enterprise/EBITDA | -0.04 |
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -2,209.32 |
| Operating Margin | -2,177.05 |
| Return On Assets | -4.37 |
| Return On Equity | -4.65 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -58.34M |
| Net Income | -58.92M |
| Diluted EPS | -14.85 |
| Total Cash | 561,237 |
| Total Cash/Share | 0.04 |
| Total Debt | 1.68M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 2.13 |
| Book Value Per Share | 0.78 |
| 52-Week Change | -97.75 |
| 52-Week High | 11 |
| 52-Week Low | 0.1 |
| Moving Average 50 Days | 0.16 |
| Moving Average 200 Days | 1.9 |
| Average Volume | 2.25M |
| Shares Outstanding | 15.17M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.01 |
| Last Split Factor | 1:60000 |
| Last Split Date | January 29, 2025 |